Phase I/II Clinical Study to Evaluate VB15010 Tablets in Patients With Advanced Solid Tumors

NCT06819215 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

RECRUITING

Status

188

Enrollment

INDUSTRY

Sponsor class

Conditions

Cancer
Neoplasms
Neoplasms, Breast
Tumor
PARP
Ovarian Neoplasms
Prostatic Cancer
Pancreatic Cancer
Breast Cancer
Biliary Cancer
Colorectal Cancer

Interventions

DRUG: VB15010

Sponsor

Zhejiang Yangli Pharmaceutical Technology Co., Ltd.

Collaborators

[object Object]